Title: Rethinking the Role of Magic Mushrooms in NHS Depression Treatment

Larissa Hope attributes her recovery from severe mental health struggles to psilocybin, the psychoactive compound found in magic mushrooms. The substance, which she consumed under strict clinical supervision, proved to be a pivotal moment in her life, particularly because conventional antidepressants had failed to provide relief. At 17, Hope was beginning her acting career on the TV series Skins. However, the sudden attention triggered long-suppressed trauma. Recalling the experience, she described an overwhelming emotional release. “When I experienced it, I burst out crying,” she recalled. “It was the first time in my life I had ever felt a sense of belonging and safety in my body. I kept saying, ‘I’m home, I’m home.’” Nearly two decades later, Hope insists that this session, combined with therapy, was instrumental in helping her overcome suicidal ideation.

Hope’s positive outcome stands in stark contrast to the experiences of Jules Evans, a university researcher who had a profoundly negative reaction to psychedelics. At age 18, Evans took LSD for recreational purposes, an event he now describes as inducing a “deluded” state. “I believed that everyone was talking about me, criticising me, judging me. I thought, I've permanently damaged myself; I've permanently lost my mind,” he said. He characterized the episode as the most terrifying experience of his life. Today, Evans leads the Challenging Psychedelic Experiences Project, an initiative designed to support individuals suffering adverse effects after using psychedelics. He noted that the incident led to years of social anxiety, panic attacks, and eventually a diagnosis of post-traumatic stress disorder (PTSD).

These divergent narratives encapsulate the central dilemma confronting medical professionals, policymakers, and regulators: should physicians be permitted to prescribe magic mushrooms and other promising psychedelic compounds? This debate has intensified following a wave of recent studies indicating that such substances may offer relief for conditions ranging from depression and obsessive-compulsive disorder to PTSD, trauma, and addictions related to alcohol and gambling.

Currently, the use of psychedelic medicine is prohibited unless conducted within authorized research frameworks or clinical trials. Since 2022, over 20 trials have investigated various psychedelic treatments for these disorders. While numerous studies report positive outcomes, others present mixed or ambiguous data, with only a small minority showing no benefit on primary measures. The UK’s medicines regulator is currently awaiting results from a major clinical trial conducted by Compass Pathways, a British biotech company, to help determine whether to loosen current restrictions and permit the use of psychedelic medicines outside of research settings. That trial’s findings are expected later this year.

Prof Oliver Howes, chair of the Royal College of Psychiatrists' Psychopharmacology Committee, remains optimistic about the potential of these treatments within the NHS. He views psychedelics as a vital addition to the mental health toolkit. “One of the key messages is that this is something we desperately need - more treatments and better treatments for mental health disorders,” he stated. He highlighted that these therapies are particularly intriguing because they have demonstrated efficacy in small-scale studies and may offer faster results. However, he urged caution, emphasizing the necessity of robust evidence to avoid overhyping the benefits. “It's really important that we get evidence and not overhype the potential benefits.”

Other experts have echoed the need for restraint. A report issued by the Royal College of Psychiatrists in September 2025 cautioned against the potential risks associated with psychedelics. Medical professionals continue to stress that beyond being illegal, recreational use of these drugs can be dangerous. Historically, the consumption of substances like magic mushrooms, opium, and cannabis has been intertwined with civilization, serving both ritualistic and recreational purposes. This tradition continued through the 1960s and 1970s, when LSD also gained significant cultural traction.

Source: BBC News Generated at: 2026-01-02 15:47:15 UTC